UW-Madison is starting a center to expand its research on psychedelic drugs such as psilocybin and MDMA, which have shown promise in treating conditions such as depression and post-traumatic stress disorder.
University Communications
UW-Madison is starting a center to expand its research on psychedelic drugs such as psilocybin and MDMA, which have shown promise in treating conditions such as depression and post-traumatic stress disorder.